Literature DB >> 9492249

Roche, FDA announce new drug-interaction warnings for mibefradil.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9492249     DOI： 10.1093/ajhp/55.3.210a

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.

Authors:  T Prueksaritanont; B Ma; C Tang; Y Meng; C Assang; P Lu; P J Reider; J H Lin; T A Baillie
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes.

Authors:  K R Yeo; W W Yeo
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.